Original Research
Accepted on 06 Feb 2025
Transduction of Hematopoietic Stem and Progenitor Cells By an MECP2 Lentiviral Vector Improves Rett Syndrome Phenotypes
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1545391
Volumes
4 Publications
Review
Published on 29 Jan 2025
Non-enzymatic protein targeting agents as a promising strategy for cancer treatment
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1520734
- 339 views
Perspective
Accepted on 24 Jan 2025
Perspective: How complex in vitro models (CIVMs) are addressing the challenges of predicting drug induced liver injury (DILI)
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1536756
Editorial
Accepted on 21 Jan 2025
Advancing Drug Discovery Using Single Cell Multiomics with Stem Cell Platform
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1561985